HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 6, 4959-4967, February 11, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/6/4959    most recent M410078200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by She, H. Articles by Tsukamoto, H. Search for Related Content PubMed PubMed Citation Articles by She, H. Articles by Tsukamoto, H. Social Bookmarking                      What's this?

Adipogenic Transcriptional Regulation of Hepatic Stellate Cells^*

Hongyun She, Shigang Xiong, Saswati Hazra, and Hidekazu Tsukamoto¶

From the Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033 and the Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California 90073

Hepatic stellate cells (HSC) undergo transdifferentiation (activation) from lipid-storing pericytes to myofibroblastic cells to participate in liver fibrogenesis. Our recent work demonstrates that depletion of peroxisome proliferator-activated receptor (PPAR) constitutes one of the key molecular events for HSC activation and that ectopic expression of this nuclear receptor achieves the phenotypic reversal of activated HSC to the quiescent cells. The present study extends these findings to test a novel hypothesis that adipogenic transcriptional regulation is required for the maintenance of HSC quiescence. Comparative analysis of quiescent and activated HSC in culture reveals higher expression of putative adipogenic transcription factors such as CCAAT/enhancer-binding protein (C/EBP) , C/EBP, C/EBP, PPAR, liver X receptor , sterol regulatory element-binding protein 1c and of adipocyte-specific genes in the quiescent cells. Conversely, activated HSC have increased expression of PPAR, a transcription factor known to promote fatty acid oxidation. A treatment of activated HSC with the adipocyte differentiation mixture (isobutylmethylxanthine, dexamethasone, and insulin) or ectopic expression of PPAR or SREBP-1c in these cells, induces a panel of adipogenic transcription factors, reduces PPAR, and causes the phenotypic reversal to quiescent HSC. These results support the importance of adipogenic transcriptional regulation in HSC quiescence and provide a new framework for identifying novel molecular targets for the treatment of liver cirrhosis.

Received for publication, September 1, 2004 , and in revised form, October 19, 2004.

^* This work is supported by National Institutes of Health Grants R37 AA006603, P50 AA11999, R24 AA12885 (Non-Parenchymal Liver Cell Core), and P30 DK48522 (Molecular Biology and Confocal Microscopy Cores) and by the Medical Research Service of Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed: Keck School of Medicine of the University of Southern California, 1333 San Pablo St., MMR-402, Los Angeles, CA 90033-9141. Tel.: 323-442-5107; Fax: 323-442-3126; E-mail: htsukamo{at}usc.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF]

				J. H. Cheng, H. She, Y.-P. Han, J. Wang, S. Xiong, K. Asahina, and H. Tsukamoto Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G39 - G49. [Abstract] [Full Text] [PDF]

				J. K. Sicklick, S. S. Choi, M. Bustamante, S. J. McCall, E. H. Perez, J. Huang, Y.-X. Li, M. Rojkind, and A. M. Diehl Evidence for epithelial-mesenchymal transitions in adult liver cells Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G575 - G583. [Abstract] [Full Text] [PDF]

				M. J. Bahr, J. Ockenga, K. H. W. Boker, M. P. Manns, and U. J. F. Tietge Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E199 - E206. [Abstract] [Full Text] [PDF]

				F Marra Thiazolidinediones and hepatic fibrosis: don't wait too long Gut, July 1, 2006; 55(7): 917 - 919. [Full Text] [PDF]

				S. Yavrom, L. Chen, S. Xiong, J. Wang, R. A. Rippe, and H. Tsukamoto Peroxisome Proliferator-activated Receptor {gamma} Suppresses Proximal {alpha}1(I) Collagen Promoter via Inhibition of p300-facilitated NF-I Binding to DNA in Hepatic Stellate Cells J. Biol. Chem., December 9, 2005; 280(49): 40650 - 40659. [Abstract] [Full Text] [PDF]

				M. Ruehl, U. Erben, D. Schuppan, C. Wagner, A. Zeller, C. Freise, H. Al-Hasani, M. Loesekann, M. Notter, B. M. Wittig, et al. The Elongated First Fibronectin Type III Domain of Collagen XIV Is an Inducer of Quiescence and Differentiation in Fibroblasts and Preadipocytes J. Biol. Chem., November 18, 2005; 280(46): 38537 - 38543. [Abstract] [Full Text] [PDF]

				K. Musselmann, B. Alexandrou, B. Kane, and J. R. Hassell Maintenance of the Keratocyte Phenotype during Cell Proliferation Stimulated by Insulin J. Biol. Chem., September 23, 2005; 280(38): 32634 - 32639. [Abstract] [Full Text] [PDF]